
Vrift TZ 1000mg/125mg Injection
Marketer
Vrinda Life
Salt Composition
Ceftriaxone (1000mg) + Tazobactum (125mg)
Overview Vrift TZ 1000mg/125mg Injection
Vrift TZ Injection (1000mg/125mg) combines medications to combat diverse bacterial infections. Its action inhibits microbial proliferation, thus curbing infection spread. Administration must be solely under a physician's guidance; adhere strictly to the prescribed schedule. Complete the entire course, even with symptom improvement; premature cessation may reduce efficacy. Potential side effects include nausea, vomiting, diarrhea, and dyspepsia. Report worsening side effects immediately; seek urgent medical attention for allergic reactions (rash, pruritus, edema, dyspnea). Inform your doctor about all current medications before use. Pregnant or lactating individuals require prior medical consultation. Alcohol consumption should be avoided due to potential increased drowsiness. While it generally doesn't impair driving, refrain if drowsiness or dizziness occurs. Adequate rest, nutrition, and hydration promote recovery. Laboratory and diagnostic tests may be ordered to monitor therapeutic response.
Uses of Vrift TZ 1000mg/125mg Injection
Infections caused by bacteria
Major Benefits of Vrift TZ 1000mg/125mg Injection:
This medication will be administered by your physician or their designated nurse; self-medication is strictly prohibited.
Common Side effects of Vrift TZ 1000mg/125mg Injection:
- Diarrhea
- Increased liver enzymes
- Allergic reaction
- Rash
How to use Vrift TZ 1000mg/125mg Injection:
This medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.
How Vrift TZ 1000mg/125mg Injection works:
Ceftriaxone/Tazobactam 1000mg/125mg (Vrift TZ) injection combines a cephalosporin antibiotic (Ceftriaxone) with a beta-lactamase inhibitor (Tazobactam). Ceftriaxone's mechanism involves disrupting bacterial cell wall synthesis, hindering bacterial survival. Tazobactam counteracts bacterial resistance mechanisms, thereby improving Ceftriaxone's effectiveness.
SAFETY ADVICE
AlcoholSAFE
Ingestion of alcohol alongside Vrift TZ 1000mg/125mg Injection poses no known adverse reactions.
PregnancySAFE IF PRESCRIBED
The injectable medication Vrift TZ (1000mg/125mg) is typically deemed safe for use during pregnancy. Preclinical trials using animal models revealed minimal or no harmful effects on fetal development; however, clinical data from human studies are currently scarce.
Breast feedingCAUTION
Administering Vrift TZ 1000mg/125mg Injection to breastfeeding mothers requires careful consideration. Lactation should be temporarily discontinued throughout the mother's treatment course and until the medication is fully cleared from her system.
DrivingUNSAFE
Administering Vrift TZ 1000mg/125mg Injection might reduce vigilance, impair vision, and induce drowsiness or dizziness. Refrain from driving if such effects manifest.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Vrift TZ 1000mg/125mg Injection to individuals with renal impairment. Physician consultation is recommended.
LiverCAUTION
Exercise caution when administering Vrift TZ 1000mg/125mg Injection to individuals with severe hepatic impairment; dosage modification may be necessary. Consult a physician. Dosage alteration for Vrift TZ 1000mg/125mg Injection is not advised for patients exhibiting mild to moderate liver dysfunction.
What if you forget to take Vrift TZ 1000mg/125mg Injection :
Should you forget a scheduled dose of Vrift TZ 1000mg/125mg Injection, seek immediate medical advice.
Facts to Know About Vrift TZ 1000mg/125mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |
